19 February 2015

February newsletter in 60 seconds

Two years after its launch, the LSIPR monthly is having a re-brand. This issue will be the final one published in a PDF format, as in March we are switching to a ‘digital first’ strategy.

Although until now we have provided access to each month’s content in both PDF and online formats, we will now produce news and analysis only on our website, lifesciencesipreview.com, before emailing it to you more regularly than before.

Under the new strategy, we will send out a weekly newsletter with the best content from the previous seven days, and in the final week of each month provide a round-up of the most interesting content. You can expect to read relevant and detailed news stories covering the most important issues affecting intellectual property lawyers in the life sciences field, as well as more in-depth features from our journalists and industry specialists.

In this final issue in the PDF format, we ask whether the gene patent’s days are numbered in the US, as Myriad Genetics seems to have thrown in the towel in its fight to protect patents covering its BRCA diagnostic tests. With an assessment of the company’s fortunes in other jurisdictions, we provide a different spin on a well-trodden but practically important and interesting topic.

We hope you enjoy the new form of coverage.

Ed Conlon, Group Editor

More on this story

article

January newsletter in 60 seconds

30 January 2015 Think of the word ‘counterfeit’ and your mind is likely to conjure up images of poorly made electronic goods, branded merchandise missing a letter or two, or market traders selling goods whose prices seem too good to be true.

article

November newsletter in 60 seconds

28 November 2014 The lights of Oxford and Cambridge University might shine brightest, but there is more than a flicker of success at other academic institutions in the UK. One of those, the University of Manchester, boasts 25 Nobel Prize winners and has housed academic masterminds such as Alan Turing.